To investigate the possible relationship between hypertension and cancer, a retrospective analysis was carried out using a database including 1225 cases, of which 552 were hypertensives and 673 normotensives. Seventy cases of cancers with different origins were found during a 17-year follow-up. Odds ratio (OR) for occurrence of cancer was calculated. It was shown that an age over 40 years, male sex, alcohol-taking, systolic and diastolic blood pressures (SBP/DBP) were the five risk factors for the occurrence of cancers, while occupation, smoking, body mass index, left ventricular hypertrophy, and antihypertensive medication had no effect on cancer incidence. Hypertensives were at a high risk of overall cancer incidence with OR 2.2 (P Ͻ 0.01). After stratification of age, OR for hypertensives aged 40-49 years old with SBP у140 mm Hg or DBP у90mm Hg was 3.18 and 2.98
Introduction
Cardiovascular diseases and malignant tumours are the two main causes of death for human beings. It is well known that cancers are characterised by cell proliferation. However, there is increasing evidence that heightened proliferation is present in many cardiovascular disorders, such as hypertension and atherosclerosis. Folkow 1 proposed that abnormalities of proliferative pathways in vascular smooth muscle cells are the hallmark of hypertension, leading to increased peripheral resistance. Higher organto-body weight ratio has been observed in genetic animal models. Cultured smooth muscle cells derived from spontaneously hypertensive rats are characterised by shortening of the cell cycle and increased proliferation. Proliferation of fibroblasts have been recognised in hypertensive left ventricular hypertrophy. Migration of arterial medial smooth muscle cells into the intimal layer and subsequent proliferation and the change from contractile to synthetic phenotype have been implicated in atherosclerosis and restenosis after angioplasty. Overexpression of many onco-genes, such as c-fos, cmyc, c-fms and c-sis, which are the genes for some growth factors and regulatory proteins and associated with over-proliferation of cancer cells, have also been identified in these proliferative and synthetic smooth muscle cells. [2] [3] [4] To some extent, hypertension shares many characteristics with the process of abnormal cell proliferation associated with cancer, and many proliferative and intracellular signalling pathways found to be abnormal in hypertension were originally described in neoplastic growth. These observations of abnormal growth in hypertension provoke the question: is hypertension associated with a higher risk of cancer? 5 In fact, in some prospective cohort studies, a modest direct association between blood pressure levels and the overall risk of death from cancer has been reported. [6] [7] [8] [9] [10] In addition, two reports described a somewhat greater incidence of cancer among patients receiving treatment with a calcium antagonist than among others in the population studied. 11, 12 Some investigators argued that this result may have been affected by confounding factors. 13 It is not clear how far the association may be due to confounding, for example with the use of antihypertensive medication or cigarette smoking. Recently, some researchers reported that there was no significant association between cancer and calcium antagonists. [14] [15] [16] [17] It is possible that hypertension per se is a risk factor for cancer. However, analyses based on the totality of evidence from a large number of cohort studies have not demonstrated such an association. 13 To gain more evidence to reveal the possible relationship between hypertension and cancer in a Chinese population, a database set up for a hypertension screening with 17 year's followup in the southern part of Fujian province P.R. China [18] [19] [20] was used to carry out this case-control study.
Subjects and methods
The original hypertension screening was established in 1974 in rural villages in the southern part of the Fujian province, including Yongchun, Anxi, Quanzhou and Chendi counties. Individuals over 15 years old were screened for hypertension. Each subject underwent the same protocol described previously. [18] [19] [20] Briefly, the determination of sitting blood pressure after 30 min rest with a mercury sphygmomanometer (Korotkoff phase I and V) was used. Blood pressure was calculated as the mean of the two readings on three consecutive days. Measurement of body weight and height, physical check up, quantification of fasting plasma cholesterol, triglyceride and serum glucose, routine tests of blood and urine, records of 12-lead resting ECG, and examination of ocular fundus were routinely performed at the same time. Established hypertension was defined as systolic blood pressure (SBP) у160 and/or diastolic blood pressure (DBP) у95 mm Hg. Borderline hypertension was defined as SBP 140-159 and/or DBP 90-94 mm Hg (18.7-21.3/12-12.9 kPa). A total of 635 hypertensives, 154 borderline and 481 established, were found from 26 642 screened individuals. A cohort of age, sex, occupation and region-matched normotensives served as control. They were randomly selected from the lists of local communities at the time of recruitment of the hypertensives. The acceptable difference of age between normotensives and hypertensives was within 5 years. Thereafter, information on stroke, cardiovascular disease deaths, cancer and deaths due to other causes was obtained annually by physicians responsible for local medical care in these counties. An interim and a final visit was carried out by our hypertension division in 1985 and 1991 and further data were accumulated. At the final visit, 134 borderline and 418 established hypertensives were followed up, accounting a response rate of 86.9%. On these occasions the investigations cited above were repeated. After reviewing the documents appertaining to deaths, the medical histories and courses, the death certification from local hospitals, and interviews with patient's family members, the probable causes of death were established by a three-physician panel. The causes included: stroke, cardiac diseases, cancers, and others (renal failure, unexpected accidents, etc). The diagnosis of cancers was based on the medical history, physical examination, type B ultrasonography, X-ray, gastrofibroscopic and enteroscopic examinations, and surgical operation, most cases were confirmed by biopsy. No other special searches for cancer amongst hypertensives were conducted. Depending on which come first, follow-up ended for all patients at the time of death or the end of this survey.
A Foxbase database was set up in 1991 when the screening was completed. [18] [19] [20] A total of 1225 cases were included in the database. Seventy cases of incident cancers were found during 17 years follow-up, of which 69 died. These data were used to carry out this nested case-control study, and the remaining 1155 subjects included in the database served as controls. Odds ratio (OR) was calculated. MantelHaenszel's 2 test was used to determine the significance of the OR and non-conditional logistic regression was performed to assess the independent risk factors for cancer. Analyses were performed using Multr software and EpiInfo 6.0.
Results

Characteristics of the study population
A total of 1225 cases, 757 female and 468 male, were involved in this study. The average age was 49.1 ± 12.9 years. Five hundred and fifty-two (552) patients were diagnosed as hypertensives, comprising 418 established hypertensives aged 54.8 ± 11.9 and 134 borderline hypertensives aged 51.3 ± 12.0. There were 673 normotensives aged 45.0 ± 12.6. Of 70 cases of cancer, 40 male and 30 female, 26 occurred in normotensives, 35 in established hypertensives, and nine in borderline hypertensives, on the basis of blood pressure measurement at the start of screening. The average age of the cancer patients was 55.0 ± 9.6 years 52.3 ± 8.3 for male and 58.6 ± 10.0 for female, respectively). Table 1 shows clearly that about 75% of cancers arose in the digestive system. Of these stomach cancer was the most common in both normotensives and hypertensives. There was no significant difference in the specific sites of cancer between normotensives and hypertensives.
The sites of cancer
Factors related to cancer incidence
As shown in Table 2 , age (above 40 years old), gender (male), alcohol consumption, SBP and DBP were the five risk factors significantly associated with cancer incidence. The cancer incidence increased markedly in those who were aged more than 40 years (OR 20.24; 95%CI 2.798-146.46, P Ͻ 0.01). The risk for cancer increased steadily with age (Trend test 2 = 16.72, P Ͻ 0.0001). The risk of cancer for males was higher than that for females (OR 2.26; 95%CI 1.35-3.81, P = 0.00078), while the cancer risk for those taking alcohol was higher than those subjects not consuming alcohol (OR 3.58). The odds ratios for those with SBP у140 mm Hg and DBP у90 mm Hg were 2.49 and 3.33 respectively. Both established and borderline hypertensives were at higher risk of cancer than normotensives ( Table  3 ). The odds ratio for those hypertensives either based on SBP or DBP was 2.2 (P Ͻ 0.01). Occupations, smoking, body mass index, left ventricular hypertrophy according to ECG criteria, and antihypertensive medication had no effect on cancer incidence.
Relationship between cancer and hypertension
To take account of the possible influence of age on cancer incidence, the relation between cancer incidence and SBP and DBP was analysed after stratification of age by dividing patients into three groups of 40-49, 50-59, and Ͻ60 years. It was shown that higher cancer incidence in hypertensive patients with both SBP у140 mm Hg and DBP у90 mm Hg was in the 40-49 age group. However, the cancer risk for those hypertensives aged over 50 years old based either SBP у140 mm Hg or DBP у90 mm Hg was slightly, but not significantly, higher than normotensives (Tables 4 and 5 ), suggesting that the higher risk in these hypertensives aged over 50 years old was mainly related to increased age. That is, hypertensives were at a higher risk of cancer 10 years earlier than normotensives. To further elucidate the relationship between hypertension and cancer after excluding complicated impacts of age, sex and alcohol-taking on cancer incidence in the population studied, analysis was performed in two steps. Firstly, non-alcohol taking subjects were selectively used to determine the relation between blood pressure and cancer after adjustment of sex. It was found that the OR of cancer occurrence for non-alcohol taking male hypertensives with SBP у140 mm Hg or DBP у90 mm Hg were 3.6 (95%CI 1.37-9.68 P = 0.003) and 5.67 (95%CI 2.01-16.75; P Ͻ 0.001), for non-alcohol-taking female hypertensives were 7.55 (95%CI 2.10-33.19, P Ͻ 0.001) and 7.80 (95%CI 2.14 -33.79, P Ͻ 0.001). Thus, after stratification of sex and alcohol-taking, a significant correlation between cancer and SBP and DBP was demonstrated. Secondly, odds ratios were calculated after adjustment of age, sex, and alcohol-consumption. Because both SBP and DBP were demonstrated to be risk factors and the population studied was relatively small, we combined SBP у140 mm Hg and DBP у90 mm Hg as hypertension. It was shown that after adjustment of age, sex and alcohol taking, the OR of the cancer incidence was 3.45 (95%CI 1.30-9.01, P Ͻ 0.01) for male hypertensives aged over 40 years, and 5.0 (95%CI 1.56-16.67, P Ͻ 0.01) for female hypertensives aged over 40 years, indicating that blood pressure was indeed a risk factor for cancer after adjustment of age, sex and alcohol-taking (Table 6 ). To test the confounding effect between factors, multiple logistic regression analysis was performed. It was shown that an age over 40 years, male sex, alcohol-taking, and DBP were the four Table 6 Relationship between hypertension and cancer after stratification according to sex and age in non-alcohol consumer* Table 7) .
Discussion
In this case-control study, it was found that age over 40 years, male sex, alcohol-taking, SBP and DBP were risk factors for cancer incidence in the study population. Male hypertensives aged over 40 years were at a higher risk for cancer incidence, which was about two times that in normotensives. There was a significant correlation between blood pressure and cancer. The higher the blood pressure, the higher the incidence of cancer. Non-conditional logistic regression showed that DBP was an independent risk factor for cancer. It is well known that cancers are characterised by cell proliferation. In 1982, when Follow first proposed hypertension was also characterised by the proliferation of smooth muscle cells, 1 it was only regarded as a discovery of a mechanism underlying hypertension pathogenesis and was not, therefore, considered in relation to the concept of 'cancer'. Thereafter, heightened proliferation featured by enhanced DNA synthesis [21] [22] [23] and a higher organ-tobody weight ratio, have been reported early in hypertension, at least in genetic models, even as early as at birth. However, these studies did not relate these proliferative phenomena to cancer. With the deepening of research into the pathogenesis of cardiovascular diseases using cellular and molecular methods, it is evident that hypertension, atherosclerosis, and cancers share, to some extent, similar cellular and molecular characteristics. [2] [3] [4] Hyper- plasia is a feature of the arterial vasculature in hypertension, and smooth muscle cells derived from spontaneously hypertensive rats are characterised by shortening of the cell cycle, increased proliferation, and exaggerated responses to growth stimuli as seen in cancer cells. 24 Furthermore proliferation of fibroblasts is also characteristic of hypertensive left ventricular hypertrophy. 25 Epidemiologically, there have been several prospective studies reporting hypertension as a significant risk factor for cancer. [6] [7] [8] [9] [10] Clinically, many investigators have reported observational studies suggesting a relation between hypertension and cancer in the past 20 years. 5 This relation is, however, not yet clearly confirmed. It was first reported that hypertensives receiving reserpine were at higher risk of breast cancer in three retrospective studies. [26] [27] [28] This finding was regarded as representing a confounding effect of blood pressure by Dyer et al, 6 who reported that both SBP and DBP were significantly associated with cancer mortality in a prospective study after appropriate adjustment for age, cholesterol, and smoking. Thereafter, some investigators reported that the use of diuretic and beta-blockers in hypertensives increased morbidity from renal cancer. [29] [30] [31] In this study, we have demonstrated that blood pressure is an independent risk factor for cancer after adjusting for age, sex, and alcohol consumption. SBP was not significant in the multiple logistic regression analysis, which may possibly be ascribed to the coexisting high SBP and DBP in most hypertensive patients.
The sites of cancer associated with hypertension is highly controversial. As some kidney cancers cause hypertension, an increased frequency of kidney cancer is to be expected in a hypertension clinic and some investigators reported that kidney cancer was the only type to be significantly increased. 31 However, excess lung, colon genitourinary, endometrium, ovary and digestive cancer have been reported in another study. 29 In our study, the excess cancer found arose mainly in the digestive system; this accounted for around three-quarters of the total. Though this result is different from most previous work, it is consistent with the epidemiological characteristics of the local population and suggests that there may be no site specificity of cancer relating to hypertension. On the other hand, it is possible that there is an unknown underlying mechanism(s) or factor(s) that contributes to hypertension development and promotes cancer at the same time. The distribution of cancers is presumably characteristic of a Chinese population. This could be an explanation of the difference between this study and that of the Glasgow Blood Pressure Clinic in which digestive cancers formed only a small proportion of the whole.
14 This does of course presuppose that the relation between blood pressure and cancer is specific for gastrointestinal cancer, which, however, sounds a little unlikely. The 7-year specific cancer mortality for the local population at the time of screening was 1.07 per 1000 person years. 32 The lack of an association with cigarette smoking is surprising, though possibly typical of a population in which most cancers are of the digestive system. Another possibility is that the percentages of smokers in the cancer patients and controls were nearly the same (16% and 17% respectively), which masked the impact of smoking on cancer. In fact, cigarette smoking was an automatically controlled factor in this study.
Interestingly, some investigators have reported that cancer risk increases with the duration of hypertension, particularly when hypertension is diagnosed before the age of 50 years. 10, 27, 33 In this study, we found that the excess cancer risk associated with hypertension occurred in individuals aged 40-49 years, though the overall cancer risk increased with age. This may be indicative of that the risk of cancer in individuals aged over 50 years is predominantly due to an age-related factor, while raised blood pressure is the most important associated of cancer in subjects under 50 years. We may draw a conclusion that hypertensives are at a high risk of cancer 10 years earlier than normotensives. Most hypertensives with cancer in this study died of cancer, rather than common complications of hypertension such as renal failure, coronary heart disease and stroke.
Both the development of cancer and hypertension may reflect the influence of multiple susceptibility genes and be influenced by many environmental factors. A putative proliferative promoting factor for smooth muscle cells may be a carcinogenic factor for other tissues acting on the same intracellular pathways. Because DNA fragmentation in apoptosis and DNA synthesis and repair are calcium-dependent-processes, it has been proposed that calcium antagonists may have effects on apoptosis and DNA synthesis. [34] [35] [36] Recently, it was reported that hypertensives treated with calcium antagonists were at a higher risk for cancer. 11, 12 However, the reliability and association between calcium antagonist use and overall cancer risk in these reports have been questioned because of the relatively small number of cases and the short period of observation. Though the number of cancer cases in this study is also relatively small, the follow-up period was long enough for the interaction between environmental factors and genetic basis of both hypertension and cancer to be observed in this study. No relation between cancer and antihypertensive medication was found in this study, which may be partially due to the most hypertensives were untreated (67.5%) or irregularly treated (24.5%) leading to a relatively small number of hypertensives receiving treatment (32.5%). The medicine used for these hypertensives was mostly made up of traditional Chinese herbs, instead of calcium antagonists. Recently, some researchers reported that calcium antagnists carried no higher risk for cancer. [14] [15] [16] [17] The other shortcoming of this study was relatively small controlling factors. Unfortunately, the detailed data about dietary constitution and social-psychological status were unavailable in the original database. We believe that there was no ascertainment bias in this study because during the screening and the follow-up visits no special searches for cancer cases amongst hypertensives were conducted. Furthermore, the database used was completed years before the origination of this case-control study.
In conclusion, though other possible confounding factors cannot be excluded as a culprit of cancer at present, the result of this paper supports the notion of a direct association between hypertension and cancer.
